Meningococcal surrogates of protection?serum bactericidal antibody activity

Department of Health, Education, and Welfare

1976 • 4,071 citations

Public Health Service

1963 • 3,764 citations

HUMAN IMMUNITY TO THE MENINGOCOCCUS

1969 • 1,290 citations

HUMAN IMMUNITY TO THE MENINGOCOCCUS

1969 • 1,009 citations

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1991 • 692 citations

Infectious diseases associated with complement deficiencies

1991 • 690 citations

Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency.

1984 • 636 citations

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

2004 • 575 citations

Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.

1991 • 520 citations

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

2001 • 469 citations

Immunologic Response of Man to Group B Meningococcal Polysaccharide Vaccines

1972 • 454 citations

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1992 • 376 citations

Immunogenicity of 2 Serogroup B Outer-Membrane Protein Meningococcal Vaccines

1999 • 371 citations

Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in England

2003 • 313 citations

Serological Basis for Use of Meningococcal Serogroup C Conjugate Vaccines in the United Kingdom: Reevaluation of Correlates of Protection

2001 • 312 citations

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile

1995 • 266 citations

Impact of meningococcal C conjugate vaccine in the UK

2002 • 240 citations

Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy

1994 • 188 citations

Immunogenicity of Two Efficacious Outer Membrane Protein‐Based Serogroup B Meningococcal Vaccines among Young Adults in Iceland

1998 • 180 citations

EstimatingHaemophilus influenzaeType b Vaccine Effectiveness in England and Wales by Use of the Screening Method

2003 • 179 citations

Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease

2003 • 163 citations

New Zealand Epidemic of Meningococcal Disease Identified by a Strain with Phenotype B:4:P1.4

1998 • 149 citations

COMPLEMENT DEFICIENCIES IN PATIENTS OVER TEN YEARS OLD WITH MENINGOCOCCAL DISEASE DUE TO UNCOMMON SEROGROUPS

1989 • 147 citations

Complement deficiency states and meningococcal disease

1993 • 140 citations

Properdin deficiency in a family with fulminant meningococcal infections.

1982 • 135 citations

Familial Properdin Deficiency and Fatal Meningococcemia

1987 • 133 citations

A 10‐year serogroup B meningococcal disease epidemic in New Zealand: Descriptive epidemiology, 1991–2000

2001 • 116 citations

Assessment of the Direct Effectiveness of BC Meningococcal Vaccine in Rio de Janeiro, Brazil: A Case-Control Study

1995 • 115 citations

IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms.

1983 • 109 citations

Ongoing group B Neisseria meningitidis epidemic in São Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex

1992 • 102 citations

Effectiveness of a Mass Immunization Campaign Against Serogroup C Meningococcal Disease in Quebec

2001 • 92 citations

Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine

1998 • 78 citations

Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine

2003 • 73 citations

Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era

2003 • 69 citations

Vaccination and the Role of Capsular Polysaccharide Antibody in Prevention of Recurrent Meningococcal Disease in Late Complement Component-Deficient Individuals

1993 • 67 citations

Specificity of Bactericidal Antibody Response to Serogroup B Meningococcal Strains in Brazilian Children after Immunization with an Outer Membrane Vaccine

1998 • 62 citations

Serotype-specific outbreak of group B meningococcal disease in Iquique, Chile

1990 • 60 citations

A Study of the Virulence of Meningococci for Man and of Human Susceptibility to Meningococcic Infection

1922 • 54 citations

Humoral Immune Responses toNeisseria meningitidisin Children

1999 • 52 citations

The Relation of the Meningococcidal Activity of the Blood to Resistance to Virulent Meningococci

1918 • 34 citations

Scientific challenges for the quality control and production of group C meningococcal conjugate vaccines

2003 • 31 citations

A ‘tailor made’ vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand

2003 • 26 citations

The Action of Human Blood on the Meningococcus.

1934 • 4 citations